Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
https://scr.zacks.com/News/Press-Releases/Press-Release-Details/2020/Zenith-Epigenetics-ZEN-3694-Resistance-is-Futile-/default.aspx